← Back to Search

StriveWeekly for Anxiety

N/A
Waitlist Available
Research Sponsored by Harvard University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
enrolled as a student at Harvard College (academic year 2021-2022)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to posttest (~8 weeks)
Awards & highlights

Study Summary

This study is evaluating whether a program that has previously demonstrated effectiveness with university students in reducing anxiety and depression symptoms will still be effective after the unprecedented amount of stressors during a global pandemic.

Eligible Conditions
  • Anxiety
  • Depression
  • Stress

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to posttest (~8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to posttest (~8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Depression Anxiety and Stress Scale (DASS-21)
Secondary outcome measures
Perceived Stress Scale
The Warwick-Edinburgh Mental Wellbeing Scales

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate Intervention ConditionExperimental Treatment1 Intervention
Participants in this condition will receive 7-8 weeks of online intervention modules. Specific modules will be selected based on a campus-wide needs assessment conducted in May 2021.
Group II: Waitlist ConditionActive Control1 Intervention
Participants in this condition will wait to receive StriveWeekly until after the Immediate Intervention condition is complete and participants from both conditions have completed the posttest survey.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
StriveWeekly
2017
N/A
~2170

Find a Location

Who is running the clinical trial?

Harvard UniversityLead Sponsor
229 Previous Clinical Trials
474,045 Total Patients Enrolled
17 Trials studying Anxiety
7,063 Patients Enrolled for Anxiety
Katie McLaughlin, PhDStudy ChairHarvard University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
StriveWeekly Trial Post-pandemic
Leslie Rith-Najarian 2021. "StriveWeekly Trial Post-pandemic". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04927845.
~137 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top